The Newsroom

Investigations  /  08.26.2020

Investigation of STAAR Surgical Company

You Have Legal Options

STAAR Surgical Company (STAA) Accused of Misleading Shareholders  

STAAR Surgical reported positive financial results for its fourth quarter and fiscal year ended January 3, 2020.  STAAR Surgical reiterated its positive financial results in its COVID-19 business update and first quarter 2020 earnings report, each time, noting the Company’s strong relationship with its distributor in China.  However, on August 5, 2020, STAAR Surgical reported decreased net sales and a net loss of $0.03 per share for second quarter 2020.  On this news, the Company’s share price fell approximately 10%, to close at $55.86 on August 6, 2020.  Then, on August 2020, J Capital Research released a scathing report asserting that the Company may have “overstated sales in China by at least one-third, or $21.6 million” meaning “all of the company’s $14 million in 2019 profit is fake.”  The report noted, “without the fraud that we believe pervades the China business, STAAR is losing money.”  On this news, the Company’s share price fell approximately 6.2%, to close at $48.25 per share on August 11, 2020. The stock continues to decline.

If you purchased STAAR Surgical Company (STAA) shares between February 26, 2020, and August 10, 2020, you have until October 19, 2020, to ask the court to appoint you lead plaintiff for the class.

 

  • If you would like more information about your rights and potential remedies please send us a message. 

  • Please Note: Neither the submission to nor the receipt of information by Robbins LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.


How can we help you?

CONTACT US TODAY | 1 800 350 6003 or [email protected]

Tell us your concerns